Supratotal Resection of Glioblastoma: Is Less More?


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
10 11 2019
Historique:
pubmed: 3 8 2019
medline: 19 12 2019
entrez: 3 8 2019
Statut: ppublish

Résumé

A relationship between the extent of resection (EOR) and survival has been demonstrated in patients with glioblastomas (GBMs). However, despite gross total resection (GTR) of the enhancing nodule (EN), GBMs usually relapse, generally near the surgical cavity. The aim of this study was to determine the prognostic role of FLAIR resection of GBMs by analyzing pre- and post-operative MRIs to estimate the EOR of EN, FLAIR-hyperintense regions and total tumor volume (TTV). Radiologic and clinical outcomes were analyzed retrospectively. Pre- and post-operative EN volume, pre- and postoperative FLAIR volume (POFV), and pre- and postoperative TTV were analyzed. EOR was then calculated for each component. Time-dependent ROC curves and cut-off values for pre- and post-operative volumes and EOR were calculated. A Kaplan-Meier analysis with the log-rank test and Cox regression analysis were then used to analyze progression-free survival (PFS) and overall survival (OS). We did not find any correlation between EOR of FLAIR-altered regions and patient survival. On the other hand, there were statistically significant relationships between the prognosis and both a preoperative EN volume less than 31.35 cm3 (p=0.032) and a postoperative EN volume less than 0.57 cm3 (p=0.015). Moreover, an EOR of EN greater than 96% was significantly associated with the prognosis (p=0.0051 for OS and p=0.022 for PFS). Our retrospective, multi-center study suggests that survival in patients with GBM is not affected by the extent of resection of FLAIR-hyperintense areas.

Sections du résumé

BACKGROUND
A relationship between the extent of resection (EOR) and survival has been demonstrated in patients with glioblastomas (GBMs). However, despite gross total resection (GTR) of the enhancing nodule (EN), GBMs usually relapse, generally near the surgical cavity.
OBJECTIVE
The aim of this study was to determine the prognostic role of FLAIR resection of GBMs by analyzing pre- and post-operative MRIs to estimate the EOR of EN, FLAIR-hyperintense regions and total tumor volume (TTV).
METHODS
Radiologic and clinical outcomes were analyzed retrospectively. Pre- and post-operative EN volume, pre- and postoperative FLAIR volume (POFV), and pre- and postoperative TTV were analyzed. EOR was then calculated for each component. Time-dependent ROC curves and cut-off values for pre- and post-operative volumes and EOR were calculated. A Kaplan-Meier analysis with the log-rank test and Cox regression analysis were then used to analyze progression-free survival (PFS) and overall survival (OS).
RESULTS
We did not find any correlation between EOR of FLAIR-altered regions and patient survival. On the other hand, there were statistically significant relationships between the prognosis and both a preoperative EN volume less than 31.35 cm3 (p=0.032) and a postoperative EN volume less than 0.57 cm3 (p=0.015). Moreover, an EOR of EN greater than 96% was significantly associated with the prognosis (p=0.0051 for OS and p=0.022 for PFS).
CONCLUSION
Our retrospective, multi-center study suggests that survival in patients with GBM is not affected by the extent of resection of FLAIR-hyperintense areas.

Identifiants

pubmed: 31373379
pii: sti35/1167

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

432-440

Auteurs

Roberto Altieri (R)

Neurosurgical Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Antonio Melcarne (A)

Neurosurgical Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Riccardo Soffietti (R)

Neuro-Oncological Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Roberta Rudá (R)

Neuro-Oncological Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Federica Franchino (F)

Neuro-Oncological Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Alessia Pellerino (A)

Neuro-Oncological Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Giuseppe La Rocca (G)

Neurosurgical Unit, Mater Olbia Hospital, Olbia, Italy, Department Of Neurosurgery, Universitá Cattolica del "Sacro Cuore", University Hospital "A. Gemelli," Rome, Italy.

Giovanni Sabatino (G)

Neurosurgical Unit, Mater Olbia Hospital, Olbia, Italy, Department Of Neurosurgery, Universitá Cattolica del "Sacro Cuore", University Hospital "A. Gemelli," Rome, Italy.

Alessandro Olivi (A)

Department Of Neurosurgery, Universitá Cattolica del "Sacro Cuore", University Hospital "A. Gemelli," Rome, Italy.

Alessandro Ducati (A)

Neurosurgical Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Pietro Zeppa (P)

Neurosurgical Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Valentina Tardivo (V)

Neurosurgical Unit, Mater Olbia Hospital, Olbia, Italy.

Cristina Mantovani (C)

Radiation Oncology Department, University of Turin, Turin, Italy.

Ilaria Chiovatero (I)

Radiation Oncology Department, University of Turin, Turin, Italy.

Stefania Martini (S)

Radiation Oncology Department, University of Turin, Turin, Italy.

Pasquale Dolce (P)

Department of Public Health, University of Naples Federico II, Naples, Italy.

Riccardo Savastano (R)

Department of Medicine and Surgery, University of Salerno, Salerno, Italy.

Michele Maria Lanotte (MM)

Neurosurgical Unit, Department of Neuroscience, University of Turin, Turin, Italy.

Francesco Zenga (F)

Neurosurgical Unit, Mater Olbia Hospital, Olbia, Italy.

Diego Garbossa (D)

Neurosurgical Unit, Mater Olbia Hospital, Olbia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH